HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuko Naya Selected Research

Yuko Naya Research Topics

Disease

6Neoplasms (Cancer)
08/2022 - 01/2013
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2020 - 01/2014
2Hepatocellular Carcinoma (Hepatoma)
07/2015 - 05/2015
1Lymphoma (Lymphomas)
06/2022
1Non-alcoholic Fatty Liver Disease
01/2020
1Liver Diseases (Liver Disease)
01/2020
1Silicosis
08/2019
1Idiopathic Pulmonary Fibrosis
08/2019
1Occupational Diseases (Occupational Disease)
08/2019
1Hyperplasia
08/2019
1Pulmonary Fibrosis (Fibrosing Alveolitis)
08/2019
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Inflammation (Inflammations)
01/2018
1Acute Kidney Injury (Acute Renal Failure)
01/2018
1Breast Neoplasms (Breast Cancer)
01/2016
1Carcinogenesis
04/2014
1Tics (Tic)
04/2014
1Melanoma (Melanoma, Malignant)
01/2014
1Colonic Neoplasms (Colon Cancer)
06/2013
1Hemangiopericytoma
01/2013
1Cataract (Cataracts)
01/2012

Drug/Important Bio-Agent (IBA)

3Amino Acid Transport Systems (Amino Acid Transporter)IBA
08/2022 - 05/2015
2Indicators and Reagents (Reagents)IBA
08/2022 - 01/2020
2Amino AcidsFDA Link
08/2022 - 05/2015
2Lipoproteins (Lipoprotein)IBA
01/2020 - 06/2013
1Essential Amino AcidsIBA
08/2022
1Immunoglobulin G (IgG)IBA
06/2022
1Immunoglobulin A (IgA)IBA
06/2022
1Immunoglobulin M (IgM)IBA
06/2022
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
06/2022
1VLDL LipoproteinsIBA
01/2020
1Silicon Dioxide (Silica)FDA LinkGeneric
08/2019
1Keratins (Keratin)IBA
08/2019
1VimentinIBA
08/2019
1Bleomycin (Blenoxane)FDA LinkGeneric
08/2019
1CytokinesIBA
01/2018
1Cisplatin (Platino)FDA LinkGeneric
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018
1ZincIBA
01/2018
1Therapeutic UsesIBA
01/2016
1TriterpenesIBA
01/2014
1lupeolIBA
01/2014
1dopachrome isomeraseIBA
01/2014
1Microphthalmia-Associated Transcription FactorIBA
01/2014
1Differentiation AntigensIBA
01/2014
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2014
1Hypolipidemic Agents (Antihyperlipidemics)IBA
06/2013
1Bevacizumab (Avastin)FDA Link
01/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013

Therapy/Procedure

2Therapeutics
01/2016 - 04/2014
1Erythrocyte Transfusion
01/2020
1Oncolytic Virotherapy
01/2016
1Cataract Extraction
01/2012
1Phacoemulsification
01/2012
1Capsulorhexis
01/2012